Pl. Mccollam et al., CAUCASIAN VERSUS AFRICAN-AMERICAN DIFFERENCES IN OROSOMUCOID - POTENTIAL IMPLICATIONS FOR THERAPY, Pharmacotherapy, 18(3), 1998, pp. 620-626
We conducted a prospective, nonrandomized study in healthy volunteers
to determine if racial differences exist in orosomucoid (ORM) and its
variants, and to examine quinidine and lidocaine binding to the protei
n. Total ORM serum concentrations were measured by Laurell-Rocket immu
noelectrophoresis. Allele types were determined by isoelectric focusin
g and immunoblotting. Total and unbound quinidine and lidocaine concen
trations were measured with standard fluorescence polarization immunoa
ssays after ultrafiltration. The frequency of the common ORM alleles w
as similar between 38 Caucasians and 67 African-Americans. Mean total
ORM concentration was significantly lower in Caucasians (57.3 +/- 25.4
vs 73.2 +/- 33.9 mg/dl, p=0.01). However, more Caucasians took oral c
ontraceptives, which may have decreased ORM concentrations. Quinidine
unbound fraction (UF) was related to ORM phenotype. The highest UF was
found with ORM 1-S (p=0.009). There were no significant relationships
between ORM phenotype and lidocaine UF Overall, African-Americans had
higher ORM concentrations than Caucasians. Quinidine binding showed s
ignificant relationships to specific ORM variants.